Name | 1-(4-bromophenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-one |
---|---|
Synonyms |
1-(4-bromo-phenyl)-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one
1-(4-bromophenyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one 1H-Pyrazolo[3,4-d]pyrimidin-4-ol, 1-(4-bromophenyl)- 1-(4-Bromophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one |
Density | 1.8±0.1 g/cm3 |
---|---|
Boiling Point | 394.6±42.0 °C at 760 mmHg |
Molecular Formula | C11H7BrN4O |
Molecular Weight | 291.103 |
Flash Point | 192.4±27.9 °C |
Exact Mass | 289.980316 |
PSA | 63.83000 |
LogP | 1.62 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.787 |
HS Code | 2933990090 |
---|
~% 864872-05-9 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/50946 A1, 2006 ; Location in patent: Page/Page column 52 ; WO 2006/050946 A1 |
Precursor 2 | |
---|---|
DownStream 1 | |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |